about
Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinomaRisk factors for hepatocellular carcinoma in IndiaInhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analoguesInhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracilStatus of hyperthermia in the treatment of advanced liver cancer.Cloning and characterization of human IC53-2, a novel CDK5 activator binding protein.Thermal ablative therapy for malignant liver tumors: a critical appraisal.Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver.A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma.Update on diagnosis, management, and prevention of hepatitis B virus infection.Screening for hepatocellular carcinoma. Review and perspective.Hepatitis B in pregnancy.Hepatitis B testing and vaccination in immigrants attending English as a second language classes in British Columbia, Canada.Multimodality therapy and liver transplantation for hepatocellular carcinoma: a 14-year prospective analysis of outcomes.Recent developments in the first detection of hepatocellular carcinomaDiagnostic and prognostic tumor markers in the gastrointestinal tract.Cancer Control Research among Cambodian Americans in Washington.Role of ultrasound guided fine needle aspiration biopsy in the diagnosis of hepatocellular carcinoma.Review of 336 patients with hepatocellular carcinoma at Songklanagarind HospitalEpidemiology of primary and secondary liver cancers.Percutaneous tumor ablation with radiofrequency.Multilevel factors influencing hepatitis B screening and vaccination among Vietnamese Americans in Atlanta, GeorgiaHepatitis B among the Khmer. Issues of translation and concepts of illness.Desferrithiocin is a more potent antineoplastic agent than desferrioxamine.Hepatitis B knowledge and practices among Cambodian American women in Seattle, Washington.Hepatocellular carcinoma in Central Europe: prognostic features and survival.Hepatitis B awareness, testing, and knowledge among Vietnamese American men and women.Factors associated with hepatitis B testing among Cambodian American men and women.Solamargine triggers hepatoma cell death through apoptosisHepatitis B mother--to--child transmission.Natural history and prognostic factors of primary hepatocellular carcinoma: study of 70 untreated patients.Genetic variation in the NBS1 gene is associated with hepatic cancer risk in a Chinese population.Knowledge of hepatitis B and vaccination status of some expatriate ethnic groups of blue collar workers in northern saudi arabiaHigh-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis.Cancer, Cancer Risk Factors, and Community-Based Cancer Control Trials in Vietnamese AmericansPromising Urinary Protein Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients.Immunological treatment of liver tumorsRecombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial.Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection.
P2860
Q24563988-31C4D0DF-1BFF-475C-9324-A96F1EB81764Q26830794-7D72D70A-579E-4BF6-8A86-D9C182BE41ADQ28321734-8806A0E4-3B1E-4479-B1D1-70809C6C8005Q28379171-1DFDEBA6-7CBE-4D79-8908-55F6348753F3Q30704873-DCD4FCE7-218B-4E12-93B9-753369E2BD3EQ30926657-8364F09A-0126-4547-B23F-5CDC7EB29914Q30932507-47CA1008-30FE-4EFA-AEF1-9F75247B2310Q33208655-AD524A7F-492D-42FB-9625-41918829EAD4Q33493146-578F908C-23F1-4988-81CF-AB57C885A7B4Q33588921-0F0D0BB7-A72C-4E23-A72A-8CB7BFF68B2CQ33616024-9CA2D008-4902-45E0-A631-34FFD44385A6Q33617002-81082068-72C3-4973-A37F-E04022AD9D51Q33821988-A5675781-6EC8-465D-9EEF-9028BB1B1E4FQ33869846-C403BF62-A46E-4EB0-B506-082336F4E96FQ34055894-F15FFDB3-A8C0-4DC7-8EFE-338473AE6E3CQ34277292-94FAB2A0-3242-40F2-A45C-385397F28D81Q34376688-909732F2-E1F1-4ED2-9709-26054E036D34Q34393094-1308AC17-D0DA-49B7-A820-E2F78DC092AAQ34511976-BEE4D993-289A-411A-810A-E9BF078DA603Q34563350-2116E86F-A569-47E3-8A2A-20DEA6DB02A4Q34568129-98428F52-635A-4DE5-B11C-51BD1E5A9B9EQ34637513-EF9290CC-ECC6-4B35-A704-8FCB76BF7D84Q34753054-821292A3-21C1-471B-ADA7-1BC8FB598F88Q35044208-99081BCA-F61F-405F-B7E5-1E0B020F4098Q35069846-29916000-08B5-4228-8759-789DC22999C6Q35362361-FFBE0889-C5C8-4E78-B98E-39F581F19C4EQ35664674-2808123D-17F7-4E1C-9FC4-C9CEDAAE521CQ35764640-B5438DD4-8549-4C2C-A3BA-E1CDF7E9347BQ35803665-B10E9809-C46E-4129-B2B1-3680025B0B90Q35917346-FEA7EA54-C1BC-41BC-9425-2F36CB7CCDB5Q35948601-22E77D68-17D0-4810-9790-0EB899C6F3E7Q35979610-B3C901FF-ACC4-4AE7-9200-5ED40D8EBF86Q36038569-58C866F0-E247-4BAA-9D6C-C2C613704AF1Q36175681-B24B4511-09C5-47CA-9C34-CCC11C1F7490Q36179777-C1FF33CB-FD0B-4F9B-9516-791DFB5029FEQ36275230-68D37016-22A7-459D-B029-7A79B63C160AQ36316587-886DE856-0F7A-4AA8-8488-37A407711A0AQ36373254-F217BB5D-F9A7-461D-892A-63900D064049Q36467826-F262DA28-D618-49D3-B508-D444ADDD224CQ36496627-2E66EEC9-8B6E-4AAF-80A7-415AD7CA450A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
NIH conference. Hepatocellular carcinoma.
@en
type
label
NIH conference. Hepatocellular carcinoma.
@en
prefLabel
NIH conference. Hepatocellular carcinoma.
@en
P2093
P1476
NIH conference. Hepatocellular carcinoma.
@en
P2093
Di Bisceglie AM
Dusheiko GM
Hoofnagle JH
P304
P356
10.7326/0003-4819-108-3-390
P407
P577
1988-03-01T00:00:00Z